Inventor
ROCK KENNETH L
US15 patents
⚠️ This page may combine multiple inventors who share the name “ROCK KENNETH L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV MASSACHUSETTS
7 patentsUS6693176B1Feb 17, 2004
Antitumor antibodies, proteins, and uses thereof
UNIV MASSACHUSETTS24 citations89
US7807187B2Oct 5, 2010
Endogenous adjuvant molecules and uses thereof
UNIV MASSACHUSETTS3 citations62
US7935338B2May 3, 2011
Antibodies to treat cancer
UNIV MASSACHUSETTS3 citations61
US7781569B2Aug 24, 2010
Antibodies to treat cancer
UNIV MASSACHUSETTS2 citations61
US7781212B2Aug 24, 2010
Antitumor antibodies, proteins, and uses thereof
UNIV MASSACHUSETTS1 citations59
US7736860B2Jun 15, 2010
Methods of identifying compounds for the treatment of sterile inflammation
UNIV MASSACHUSETTS0 citations52
US7902339B2Mar 8, 2011
Antitumor antibodies, proteins, and uses thereof
UNIV MASSACHUSETTS0 citations49
ROCK KENNETH L
3 patentsUS8101586B2Jan 24, 2012
Methods and compositions for the treatment of sterile inflammation
ROCK KENNETH L33 citations91
US8444972B2May 21, 2013
Antitumor antibodies, proteins, and uses thereof
ROCK KENNETH L1 citations58
US8597664B2Dec 3, 2013
Endogenous adjuvant molecules and uses thereof
ROCK KENNETH L0 citations50
DANA FARBER CANCER INST INC
3 patentsUS5733550AMar 31, 1998
Method for enhancing the association of exogenous peptides with class I MHC molecules on the surface of antigen presenting cells with β-microglobulin
DANA FARBER CANCER INST INC11 citations73
US5348878ASep 20, 1994
Class I MHC-restricted T-T hybridomas, and a CD8-transfected BW5147, fusion partner therefor
DANA FARBER CANCER INST INC7 citations73
US7176186B1Feb 13, 2007
Stimulation of cell-mediated immune responses by targeted particulate genetic immunization
DANA FARBER CANCER INST INC4 citations61